You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
瑞普生物(300119.SZ):莫普欣等產品取得獸藥產品批准文號
格隆匯 04-11 19:29

格隆匯4月11日丨瑞普生物(300119.SZ)公佈,公司全資子公司瑞普(天津)生物藥業有限公司的犬、貓用驅蟲產品莫普欣通過國家一致性評價審核,獲得了由農業農村部核發的6個獸藥產品批准文號;全資子公司瑞普(保定)生物藥業有限公司獲得了由農業農村部核發的鴨坦布蘇病毒血凝抑制試驗抗原、陽性血清與陰性血清獸藥產品批准文號。

本次6個規格犬、貓用驅蟲產品通過國家一致性評價審核並獲得獸藥產品批准文號,使公司寵物驅蟲產品管線更具領先性,加速提升公司在寵物外用驅蟲市場的核心競爭力及市場份額。

鴨坦布蘇病毒血凝抑制試驗抗原、陽性血清與陰性血清生產批文的獲得,結合公司前期研製的“鴨坦布蘇病毒病滅活疫苗(HB株)”(國家一類新獸藥)以及“鴨坦布蘇病毒ELISA抗體檢測試劑盒”(國家一類新獸藥)系列產品,有助於進一步提高公司水禽產品市場份額,為公司業績提供新的增長點。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account